R1	AND Arg1:T2 Arg2:T1	
R2	Has_temporal Arg1:T4 Arg2:T5	
*	OR T9 T10
R3	AND Arg1:T9 Arg2:T8	
*	OR T13 T14 T15
R4	Subsumes Arg1:T12 Arg2:T13	
R5	AND Arg1:T18 Arg2:T17	
R6	Subsumes Arg1:T20 Arg2:T21	
*	OR T19 T20
R7	Has_value Arg1:T26 Arg2:T25	
*	OR T23 T24 T26
R8	Subsumes Arg1:T22 Arg2:T23	
R9	Has_temporal Arg1:T29 Arg2:T31	
R10	Has_temporal Arg1:T32 Arg2:T30	
T1	Drug 20 31	Clopidogrel
T2	Condition 0 16	Contraindication
T3	Condition 33 40	Smoking
T4	Condition 50 57	smokers
T5	Temporal 42 49	current
T6	Condition 75 87	quit smoking
T7	Temporal 88 108	less than six months
T8	Condition 111 121	Malignancy
T9	Mood 122 131	diagnosed
T10	Mood 135 154	under investigation
T12	Condition 157 181	Haematological disorders
T13	Condition 183 190	Anaemia
T14	Condition 192 202	malignancy
T15	Condition 204 222	bleeding disorders
T17	Person 225 230	Women
T18	Condition 234 257	child-bearing potential
T19	Drug 266 281	corticosteroids
T20	Drug 288 309	antithrombotic agents
T21	Drug 310 318	warfarin
T22	Condition 321 342	Chronic liver disease
T23	Condition 344 353	Cirrhosis
T24	Condition 355 365	malignancy
T25	Value 384 415	more than twice the upper limit
T26	Measurement 419 439	liver function tests
T28	Observation 442 460	Unable to consent.
T29	Drug 475 502	investigational study drugs
T31	Temporal 503 537	within 1 year prior to study entry
T30	Temporal 539 547	Previous
T32	Observation 548 575	participation in this study
